Drug Formulation Market to Surpass US$ 1.58 Tn Amid Increasing Demand for Oral Formulation Booming the Pharmaceutical Industry Growth in Coming Years | Future Market Insights, Inc.

East Asia drug formulation marker revenue valued to reach around US$ 320.7 Bn in 2032. Key Companies Profiled are- AstraZeneca plc., Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., AbbVie Inc. NEWARK, Del., Nov. 10, 2022...

Click to view original post